Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yihui Wen & Jennifer R Grandis. (2015) Emerging drugs for head and neck cancer. Expert Opinion on Emerging Drugs 20:2, pages 313-329.
Read now
Read now
Yi Li, Bo Li, Chun-Jie Li & Long-Jiang Li. (2015) Key points of basic theories and clinical practice in rAd-p53 (Gendicine™) gene therapy for solid malignant tumors. Expert Opinion on Biological Therapy 15:3, pages 437-454.
Read now
Read now
Guang-xia Chen, Shu Zhang, Xiao-hua He, Shi-yu Liu, Chao Ma & Xiao-Ping Zou. (2014) Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives. OncoTargets and Therapy 7, pages 1901-1909.
Read now
Read now
Articles from other publishers (47)
Bryce Wallis, Katherine Redd Bowman, Phong Lu & Carol S. Lim. (2023) The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer. Biomolecules 13:1, pages 159.
Crossref
Crossref
Reeshan ul Quraish, Tetsuyuki Hirahata, Afraz ul Quraish & Shahan ul Quraish. (2023) An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies. Cancer Informatics 22, pages 117693512211507.
Crossref
Crossref
Hiroyuki Araki, Hiroshi Tazawa, Nobuhiko Kanaya, Yoshinori Kajiwara, Motohiko Yamada, Masashi Hashimoto, Satoru Kikuchi, Shinji Kuroda, Ryuichi Yoshida, Yuzo Umeda, Yasuo Urata, Shunsuke Kagawa & Toshiyoshi Fujiwara. (2022) Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer. Molecular Therapy - Oncolytics 27, pages 3-13.
Crossref
Crossref
Jaimin R. Shah, Tao Dong, Abraham T. Phung, Tony Reid, Christopher Larson, Ana B. Sanchez, Bryan Oronsky, Sarah L. Blair, Omonigho Aisagbonhi, William C. Trogler & Andrew C. Kummel. (2022) Development of Adenovirus Containing Liposomes Produced by Extrusion vs. Homogenization: A Comparison for Scale-Up Purposes. Bioengineering 9:11, pages 620.
Crossref
Crossref
Shanmugappiriya Sivarajah, Kevin Emerick & Howard L. Kaufman. (2022) What Surgeons Need to Know About Gene Therapy for Cancer. Advances in Surgery 56:1, pages 151-168.
Crossref
Crossref
Alexandra L.G. Mahoney, Najah T. Nassif, Bronwyn A. O’Brien & Ann M. Simpson. 2022. Molecular Cloning. Molecular Cloning.
Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale & Rodrigo Esaki Tamura. (2022) The use of adenoviral vectors in gene therapy and vaccine approaches. Genetics and Molecular Biology 45:3 suppl 1.
Crossref
Crossref
敏 方. (2022) Research Progress of KNDC1 Promoting Cell Senescence. Advances in Clinical Medicine 12:03, pages 1515-1520.
Crossref
Crossref
Jote T. Bulcha, Yi Wang, Hong Ma, Phillip W. L. Tai & Guangping Gao. (2021) Viral vector platforms within the gene therapy landscape. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Uday Kumar Sukumar, Tarik F. Massoud & Ramasamy Paulmurugan. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
773
786
.
Takeshi Koujima, Hiroshi Tazawa, Takeshi Ieda, Hiroyuki Araki, Takuro Fushimi, Ryohei Shoji, Shinji Kuroda, Satoru Kikuchi, Ryuichi Yoshida, Yuzo Umeda, Fuminori Teraishi, Yasuo Urata, Hiroyuki Mizuguchi & Toshiyoshi Fujiwara. (2020) Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. Molecular Therapy - Oncolytics 17, pages 107-117.
Crossref
Crossref
Hiroshi Tazawa, Joe Hasei, Shuya Yano, Shunsuke Kagawa, Toshifumi Ozaki & Toshiyoshi Fujiwara. (2020) Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy. Cancers 12:2, pages 478.
Crossref
Crossref
N. Lynn Henry, Payal D. Shah, Irfanullah Haider, Phoebe E. Freer, Reshma Jagsi & Michael S. Sabel. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1560
1603.e12
.
Mubalake Abudoureyimu, Yongting Lai, Chuan Tian, Ting Wang, Rui Wang & Xiaoyuan Chu. (2019) Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC. Frontiers in Oncology 9.
Crossref
Crossref
Hsi-Lung Hsieh & Ming-Ming Tsai. (2019) Tumor progression-dependent angiogenesis in gastric cancer and its potential application. World Journal of Gastrointestinal Oncology 11:9, pages 686-704.
Crossref
Crossref
Saad Saffo & Tamar H. Taddei. (2019) Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies. Digestive Diseases and Sciences 64:4, pages 1016-1029.
Crossref
Crossref
Guoying Zou, Biqiong Ren, Yi Liu, Yin Fu, Pan Chen, Xiayu Li, Shudi Luo, Junyu He, Ge Gao, Zhaoyang Zeng, Wei Xiong, Guiyuan Li, Yumei Huang, Keqian Xu & Wenling Zhang. (2018) Inhibin B suppresses anoikis resistance and migration through the transforming growth factor‐β signaling pathway in nasopharyngeal carcinoma. Cancer Science 109:11, pages 3416-3427.
Crossref
Crossref
Akikazu AsadaHideki HayakawaNatsuki YanaseKanae AbeFuminori Sakurai, Hiroyuki Mizuguchi & Yasuo Urata. (2018) A Flow Cytometry-Based Method to Determine the Titer of Adenoviruses Expressing an Extraneous Gene. Biological and Pharmaceutical Bulletin 41:10, pages 1615-1619.
Crossref
Crossref
Tinglu Li, Guangbo Kang, Tingyue Wang & He Huang. (2018) Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review). Oncology Letters.
Crossref
Crossref
Wei-Wei ZhangLongjiang LiDinggang LiJiliang LiuXiuqin LiWei LiXiaolong XuMichael J. ZhangLois A. ChandlerHong LinAiguo HuWei XuDominic Man-Kit Lam. (2018)
The First Approved Gene Therapy Product for Cancer Ad-
p53
(Gendicine): 12 Years in the Clinic
. Human Gene Therapy 29:2, pages 160-179.
Crossref
Crossref
Yu XiaZhenhua DuXinyan WangXiuqin Li. (2018)
Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of
TP53
Gene Therapy
. Human Gene Therapy 29:2, pages 242-250.
Crossref
Crossref
Feng Liu, Kaya Xu, Hua Yang, Yuming Li, Jian Liu, Jixiang Wang & Zhizhong Guan. (2017) A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters. Oncology Letters.
Crossref
Crossref
Xiaoni Liu, Jianji Xu, Shuang Wang, Xiaoxiao Yu, Boxin Kou, Mengyin Chai, Yunjin Zang & Dexi Chen. (2017) Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo. International Journal of Oncology 51:4, pages 1291-1299.
Crossref
Crossref
Hiroshi Tazawa, Shinji Kuroda, Joe Hasei, Shunsuke Kagawa & Toshiyoshi Fujiwara. (2017) Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer. International Journal of Molecular Sciences 18:7, pages 1479.
Crossref
Crossref
Bo Li, Ning Gao, Zhuang Zhang, Qian‐Ming Chen, Long‐Jiang Li & Yi Li. (2017) Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China. Genes 8:3, pages 85.
Crossref
Crossref
Wen-Shu Ma, Jing-Guang Ma & Li-Na Xing. (2017) Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma. Anti-Cancer Drugs 28:2, pages 230-236.
Crossref
Crossref
Yong-Song Guan, Qing He & Qing Zou. (2016) Status quo of p53 in the treatment of tumors. Anti-Cancer Drugs 27:9, pages 811-818.
Crossref
Crossref
Jiao Zhou, Qiu-Mei Yao, Jin-Lan Li, Yan Chang, Ting Li, Wen-Ling Han, Hong-Ping Wu, Lin-Fang Li, Qi-Jun Qian & Guo-Rui Ruan. (2016) Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells. Apoptosis 21:10, pages 1179-1190.
Crossref
Crossref
Kathleen F Pirollo, John Nemunaitis, Po Ki Leung, Robert Nunan, Jana Adams & Esther H Chang. (2016) Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study. Molecular Therapy 24:9, pages 1697-1706.
Crossref
Crossref
Zhenzhen Li, Zhou Ye, Xiaolong Zhang, Qing Zhang, Dongmei Fan, Yanjun Zhang, Hongbo R. Luo, Xiangfei Yuan, Zongfang Li & Dongsheng Xiong. (2016) E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice. Oncotarget 7:32, pages 51815-51828.
Crossref
Crossref
Lin Fang, Qian Cheng, Jingjing Zhao, Yan Ge, Qi Zhu, Min Zhao, Jie Zhang, Qi Zhang, Liantao Li, Junjie Liu & Junnian Zheng. (2016) A p53-independent apoptotic mechanism of adenoviral mutant E1A was involved in its selective antitumor activity for human cancer. Oncotarget 7:30, pages 48309-48320.
Crossref
Crossref
Carlos Ribeiro, Cecília Rodrigues, Rui Moreira & Maria Santos. (2016) Chemical Variations on the p53 Reactivation Theme. Pharmaceuticals 9:2, pages 25.
Crossref
Crossref
Kiyoto Takehara, Hiroshi Tazawa, Naohiro Okada, Yuuri Hashimoto, Satoru Kikuchi, Shinji Kuroda, Hiroyuki Kishimoto, Yasuhiro Shirakawa, Nobuhiro Narii, Hiroyuki Mizuguchi, Yasuo Urata, Shunsuke Kagawa & Toshiyoshi Fujiwara. (2016) Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer. Molecular Cancer Therapeutics 15:1, pages 199-208.
Crossref
Crossref
Hiroshi Tazawa, Shunsuke Kagawa & Toshiyoshi Fujiwara. 2016. Current Strategies in Cancer Gene Therapy. Current Strategies in Cancer Gene Therapy
1
15
.
Bruna de Andrade Pereira, Leoneide E. Maduro Bouillet, Natalia A. Dorigo, Cornel Fraefel & Oscar Bruna-Romero. (2015) Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice. PLOS ONE 10:12, pages e0145260.
Crossref
Crossref
Maolan Li, Fei Zhang, Xu'an Wang, Xiangsong Wu, Bingtai Zhang, Ning Zhang, Wenguang Wu, Zheng Wang, Hao Weng, Shibo Liu, Guofeng Gao, Jiasheng Mu, Yijun Shu, Runfa Bao, Yang Cao, Jianhua Lu, Jun Gu, Jian Zhu & Yingbin Liu. (2015) Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway. Cancer Science 106:10, pages 1341-1350.
Crossref
Crossref
XIONG ZHANG, DONG-DONG QI, TING-TING ZHANG, QING-XIN CHEN, GUANG-ZHI WANG, GUANG-YU SUI, XUE-WEI HAO, SHOULI SUN, XUE SONG & YING-LI CHEN. (2015) Antitumor activity of adenoviral vector containing T42 and 4xT42 peptide gene through inducing apoptosis of tumor cells and suppressing angiogenesis. Molecular Medicine Reports 11:3, pages 2083-2091.
Crossref
Crossref
Haixi Mu, Na Wang, Lijuan Zhao, Shuman Li, Qianqian Li, Ling Chen, Xinrong Luo, Zhu Qiu, Lili Li, Guosheng Ren, Yongzhu Xu, Xiangyang Zhou & Tingxiu Xiang. (2015) Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer. Experimental Cell Research 332:2, pages 179-189.
Crossref
Crossref
Shunsuke Iizuka, Fuminori Sakurai, Kahori Shimizu, Kazuo Ohashi, Shin-ichiro Nakamura, Masashi Tachibana & Hiroyuki Mizuguchi. (2015) Evaluation of Transduction Properties of an Adenovirus Vector in Neonatal Mice. BioMed Research International 2015, pages 1-10.
Crossref
Crossref
Mireille Happy, Jordan Dejoie, Cynthia K. Zajac, Briseida Cortez, Karabi Chakraborty, Joseph Aderemi & Moira Sauane. (2015) Sigma 1 Receptor antagonist potentiates the anti-cancer effect of p53 by regulating ER stress, ROS production, Bax levels, and caspase-3 activation. Biochemical and Biophysical Research Communications 456:2, pages 683-688.
Crossref
Crossref
C. Serguera & A.-P. Bemelmans. (2014) Gene therapy of the central nervous system: General considerations on viral vectors for gene transfer into the brain. Revue Neurologique 170:12, pages 727-738.
Crossref
Crossref
Michael J. Duffy, Naoise C. Synnott, Patricia M. McGowan, John Crown, Darran O’Connor & William M. Gallagher. (2014) p53 as a target for the treatment of cancer. Cancer Treatment Reviews 40:10, pages 1153-1160.
Crossref
Crossref
Christelle En Lin Chua, Shu Ning Chan & Bor Luen Tang. (2014) Non-Cell Autonomous or Secretory Tumor Suppression. Journal of Cellular Physiology 229:10, pages 1346-1352.
Crossref
Crossref
Masashi Idogawa, Tomoko Ohashi, Jun Sugisaka, Yasushi Sasaki, Hiromu Suzuki & Takashi Tokino. (2014) Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells. Oncotarget 5:17, pages 7540-7548.
Crossref
Crossref
Juan Liu, Cen Zhang & Zhaohui Feng. (2014) Tumor suppressor p53 and its gain-of-function mutants in cancer. Acta Biochimica et Biophysica Sinica 46:3, pages 170-179.
Crossref
Crossref
Chang-quan Ling, Li-na Wang, Yuan Wang, Yuan-hui Zhang, Zi-fei Yin, Meng Wang & Chen Ling. (2014) The roles of traditional Chinese medicine in gene therapy. Journal of Integrative Medicine 12:2, pages 67-75.
Crossref
Crossref
Amy Lee Bredlau & David N. Korones. 2014.
235
259
.